This downloadable slideset reviews new, clinically relevant data on viral hepatitis and NAFLD/NASH; topics include risk of HCC in patients with viral hepatitis, HBV and HCV treatment, organ transplant from donors with HCV infection, and novel treatments for NAFLD/NASH.
Listen to downloadable audio from a live Webinar reviewing the most clinically relevant new NAFLD/NASH data. Topics include global disease burden, treatments in development, and disease monitoring.
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on the most clinically relevant new viral hepatitis data presented at AASLD 2019, including updated information on HCV incidence and management and HBV management.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.